German biopharmaceutical giant expects to forge deeper ties with China's innovation ecosystem

Global biopharmaceutical leader Boehringer Ingelheim, a CIIE regular, has accelerated product launches in China by leveraging favorable policies, deepening its healthcare commitment. #GLOBALink